Related Experiment Videos

Cross-resistance patterns related to glutathione metabolism in primary human renal cell carcinoma

G Mickisch1, S Fajta, H Bier

  • 1Department of Urology, Mannheim Hospital, University of Heidelberg, FRG.

Urological Research
|January 1, 1991
PubMed

Insights

Multidrug resistance is active in human renal cell carcinoma (RCC). Elevated glutathione levels, not GGT activity, correlate with chemoresistance patterns, impacting treatment strategies for kidney cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Renal cell carcinoma (RCC) exhibits complex chemoresistance.
  • Understanding resistance mechanisms is crucial for effective cancer therapy.

Purpose of the Study:

  • To investigate cross-resistance and collateral susceptibility patterns in human RCC.
  • To evaluate the roles of glutathione (GSH) and gamma-glutamyl transpeptidase (GGT) in chemoresistance.

Main Methods:

  • MTT microculture assay used on 59 primary human RCC cases.
  • Measurement of cellular glutathione content.
  • Assay of gamma-glutamyl transpeptidase enzymatic activity.

Main Results:

  • Coincident resistance to Vinca alkaloids and anthracyclines suggests classical multidrug resistance.
  • Elevated GSH levels correlated with resistance to platinum complexes and sensitivity to bleomycin.
  • GGT activity showed no correlation with chemoresistance patterns in RCC.

Conclusions:

  • Classical multidrug resistance mechanisms are active in human RCC.
  • Glutathione's role in binding and reduction potential significantly impacts chemoresistance.
  • GGT activity does not appear to be a major determinant of chemoresistance in this context.

Related Concept Videos